This paper titled: "EAMBES position paper for Horizon 2020 research in technologies for health and medicine: a comprehensive biomedical engineering approach for future personalized medicine and healthcare technologies" is a continuation of the Expert Policy Workshop on Biomedical Engineering at the European Parliament on March 27th 2012 hosted by the European Parliamentarian Dr Thomas Ulmer (EPP, Germany) in collaboration with EAMBES that produced ten recommendations as to contribute to the current debate on European research and innovation.
The main outcome of the Policy Workshop was: “Biomedical Engineering is a cross-disciplinary science based on Medicine, Biology and Engineering. It is fundament for a variety of highly innovative technologies and products or processes of the health care sector. Biomedical Engineering should be understood as a stand-alone discipline to better utilise resources and fully realise the corresponding opportunities. It is thus important, that the European Union recognises the full potential of Biomedical Engineering and consequently promotes collaborative research in this field“. The entire recommendation can be found at: http://www.eambes.org/news/report-on-the-expert-policy-workshop-on-biomedical-engineering
With the current position paper EAMBES would provide practical recommendation to Horizon 2020 calls on research in technologies for health and medicine. We would like to inform the national and European policy makers as well as other stakeholders about the future perspectives of this multidisciplinary domain so important for our society and elucidate our perspectives of future health technology research. In the previous Framework Programmes funding of biomedical engineering at EU level has been very fragmented and near the Horizon 2020 launch, the EU still lacks a grand vision and a consistent approach to fund for biomedical engineering.
The specific inclusion of biomedical engineering in Horizon 2020 would do much to address the growing problems that have been identified during the Commission reflection process on chronic diseases and would be a step towards addressing the problems described in the Commission Communication on Active and Healthy Ageing and novel developments of personalized medicine.